Incannex Healthcare (NASDAQ: IXHL) reported Q4 2022 earnings per share (EPS) of N/A, up N/A year over year. Total Incannex Healthcare earnings for the quarter were N/A. In the same quarter last year, Incannex Healthcare's earnings per share (EPS) was N/A.
As of Q1 2023, Incannex Healthcare's earnings has grown year over year. Incannex Healthcare's earnings in the past year totalled -$18.19 million.
What was IXHL's revenue last quarter?
Incannex Healthcare (NASDAQ: IXHL) reported Q4 2022 revenue of N/A up N/A year over year. In the same quarter last year, Incannex Healthcare's revenue was N/A.
What was IXHL's revenue growth in the past year?
As of Q1 2023, Incannex Healthcare's revenue has grown -0.95% year over year. This is 254.35 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 253.41%. Incannex Healthcare's revenue in the past year totalled $788.65 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.